Celcuity (CELC) Competitors $10.24 -0.30 (-2.85%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$10.23 -0.01 (-0.10%) As of 03/28/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELC vs. NHC, AHCO, VRDN, CDNA, AVAH, GRAL, FTRE, PNTG, CSTL, and FLGTShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include National HealthCare (NHC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), CareDx (CDNA), Aveanna Healthcare (AVAH), Grail (GRAL), Fortrea (FTRE), The Pennant Group (PNTG), Castle Biosciences (CSTL), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. Celcuity vs. National HealthCare AdaptHealth Viridian Therapeutics CareDx Aveanna Healthcare Grail Fortrea The Pennant Group Castle Biosciences Fulgent Genetics National HealthCare (NYSE:NHC) and Celcuity (NASDAQ:CELC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment, dividends and community ranking. Which has more volatility and risk, NHC or CELC? National HealthCare has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Which has stronger valuation & earnings, NHC or CELC? National HealthCare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational HealthCare$1.30B1.10$66.80M$6.5414.13CelcuityN/AN/A-$63.78M-$2.61-3.92 Do insiders & institutionals have more ownership in NHC or CELC? 56.4% of National HealthCare shares are owned by institutional investors. Comparatively, 63.3% of Celcuity shares are owned by institutional investors. 13.8% of National HealthCare shares are owned by insiders. Comparatively, 15.8% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is NHC or CELC more profitable? National HealthCare has a net margin of 10.03% compared to Celcuity's net margin of 0.00%. National HealthCare's return on equity of 6.87% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets National HealthCare10.03% 6.87% 4.68% Celcuity N/A -62.66%-39.78% Does the media refer more to NHC or CELC? In the previous week, Celcuity had 2 more articles in the media than National HealthCare. MarketBeat recorded 5 mentions for Celcuity and 3 mentions for National HealthCare. National HealthCare's average media sentiment score of 1.71 beat Celcuity's score of 0.47 indicating that National HealthCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National HealthCare 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend NHC or CELC? Celcuity has a consensus price target of $30.17, indicating a potential upside of 194.60%. Given Celcuity's stronger consensus rating and higher possible upside, analysts clearly believe Celcuity is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Celcuity 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Does the MarketBeat Community believe in NHC or CELC? Celcuity received 335 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 67.60% of users gave Celcuity an outperform vote. CompanyUnderperformOutperformNational HealthCareOutperform Votes3100.00% Underperform VotesNo VotesCelcuityOutperform Votes33867.60% Underperform Votes16232.40% SummaryNational HealthCare and Celcuity tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$380.21M$2.83B$5.63B$7.83BDividend YieldN/A22.57%4.57%4.00%P/E Ratio-3.9213.1723.3318.67Price / SalesN/A202.00388.4691.01Price / CashN/A57.5638.1634.64Price / Book1.874.356.894.23Net Income-$63.78M-$22.21M$3.20B$247.15M7 Day Performance-2.48%51.05%-2.98%-2.17%1 Month Performance8.59%12.95%1.63%-5.68%1 Year Performance-52.59%-3.70%9.45%-0.74% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity1.7128 of 5 stars$10.24-2.8%$30.17+194.6%-52.6%$380.21MN/A-3.9240Upcoming EarningsNHCNational HealthCareN/A$92.82-0.9%N/AN/A$1.43B$1.30B11.6312,400Positive NewsAHCOAdaptHealth3.5226 of 5 stars$9.74+1.5%$13.80+41.7%-7.6%$1.31B$3.26B-5.9010,900VRDNViridian Therapeutics1.3069 of 5 stars$16.04+0.8%$35.70+122.6%-17.5%$1.31B$302,000.00-3.7250Positive NewsCDNACareDx3.4617 of 5 stars$19.27+2.0%$31.83+65.2%+69.6%$1.07B$333.79M-7.14740Positive NewsAVAHAveanna Healthcare0.6999 of 5 stars$5.51+6.2%$4.94-10.4%+115.7%$1.06B$2.02B-16.2133,500High Trading VolumeGRALGrail0.7586 of 5 stars$29.13-2.1%$16.00-45.1%N/A$987.36M$125.60M0.001,360Positive NewsFTREFortrea2.5569 of 5 stars$9.98+3.3%$19.00+90.4%-80.0%$900.20M$2.70B-2.9218,000PNTGThe Pennant Group3.6969 of 5 stars$24.35+3.6%$34.80+42.9%+25.4%$838.37M$695.24M35.815,791CSTLCastle Biosciences2.4702 of 5 stars$20.03+3.8%$40.00+99.7%-10.0%$560.98M$332.07M100.16540Analyst ForecastFLGTFulgent Genetics2.9115 of 5 stars$17.37+0.8%$16.00-7.9%-21.4%$535.50M$283.47M-3.151,010Short Interest ↑Positive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies National HealthCare Competitors AdaptHealth Competitors Viridian Therapeutics Competitors CareDx Competitors Aveanna Healthcare Competitors Grail Competitors Fortrea Competitors The Pennant Group Competitors Castle Biosciences Competitors Fulgent Genetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELC) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
